Financhill
Back

Pyxis Oncology Stock Predictions

Pyxis Oncology Stock Forecast

  • Is Pyxis Oncology Stock Undervalued?
    The current Pyxis Oncology [PYXS] share price is $4.41. The Score for PYXS is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PYXS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Pyxis Oncology Stock Go Up Next Year?

Data Unavailable

Pyxis Oncology Stock Rating

Data Unavailable

Pyxis Oncology Stock Price History

Is PYXS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PYXS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
pyxisoncology.com

52-Week Data

52-Week High:
6.85
52-Week Low:
1.35

Prediction Charts

Market Cap:
256.37M
Price in USD:
4.41
Volume:
188.14K
Beta:
1.43

Technical Analysis

SMA50:
5.07
SMA100:
3.98
SMA200:
2.98
52-Wk Change:
58.63%

Stock Predictions

  • Is Pyxis Oncology stock public?
    Yes, Pyxis Oncology is a publicly traded company.
  • What is the Pyxis Oncology stock quote today?
    The Pyxis Oncology stock price is 4.41 USD today.
  • How to buy Pyxis Oncology stock online?
    You can buy Pyxis Oncology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-15 4.92 4.73 4.98 4.64
Apr-16 4.63 4.69 5.01 4.58
Apr-17 4.74 4.81 5.09 4.74
Apr-18 4.86 4.52 4.86 4.28
Apr-19 4.46 4.14 4.53 4.06
Apr-22 4.22 4.53 4.69 4.16
Apr-23 4.55 4.49 4.72 4.44
Apr-24 4.51 4.45 4.63 4.37
Apr-25 4.36 4.30 4.54 4.25
Apr-26 4.27 4.30 4.42 4.25
Apr-29 4.37 4.44 4.63 4.32
Apr-30 4.40 4.45 4.46 4.38
May-1 4.44 4.40 4.70 4.24
May-2 4.48 4.41 4.48 4.31

Pyxis Oncology Earnings

Data Unavailable

Pyxis Oncology Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.14 per share, an increase this year of $1.11 per share, and a decrease next year of $0.36 per share.

* Pyxis Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.